Cross-sectorial Rehabilitation of Patients with Lung Cancer
1 other identifier
interventional
130
1 country
1
Brief Summary
Four thousand seven hundred patients are diagnosed with lung cancer in Denmark every year. Even though cigarette smoking has declined for decades a decline in lung cancer incidence is still at least a decade away. Only 16% of these patients with lung cancer started in a municipal rehabilitation program. Aim: To investigate if the intervention "early contact conference" can facilitate acceptance of and participation in municipal rehabilitation in patients with lung cancer. Further, to investigate whether the rehabilitation improve the patients' physical ability and quality of life. Thirteen municipalities from Region Hovedstaden have agreed to participate in this cluster randomized controlled trial. The intervention will focus on creating early contact between the Department of Oncology and the municipalities. The conference call will be planned when the patient is at the hospital for the second systemic treatment and a written status will be sent to the GP after the conference video call so that hospital, municipality, and GP will all have the newest knowledge about the patient's general condition The intervention will be easy to implement in clinical practice afterwards if it is a success and the cost of the intervention is low.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 7, 2024
CompletedFirst Submitted
Initial submission to the registry
November 22, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 18, 2024
October 1, 2024
1.7 years
November 22, 2024
December 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early contact conference
• Will an "early contact conference" with the primary sector increase the number of patients with NSCLC starting rehabilitation in the municipality?
6 months after treatment start
Secondary Outcomes (1)
Quality of life
EORTC-C30 baseline, 3 weeks, 9 weeks, 6 months
Study Arms (2)
Intervention group: video conference
EXPERIMENTALNo intervention
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- patients diagnosed with NSCLC
- \. line systemic treatment
You may not qualify if:
- cannot speak, understand, and/or read Danish
- cognitive/psychologically unfit to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Camilla Ballelead
Study Sites (1)
Herlev and Gentofte Hospital
Herlev, Denmark, 2730, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator, phD student
Study Record Dates
First Submitted
November 22, 2024
First Posted
November 26, 2024
Study Start
October 7, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
December 18, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share